* Globus Medical Inc GMED.N GMED.K is expected to show a
rise
in quarterly revenue when it reports results on May 4.
* The Audubon Pennsylvania-based company is expected to
report a
10.6% increase in revenue to $254.898 million from $230.55
million a year ago, according to the mean estimate from 14
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Globus Medical Inc
is for
earnings of 51 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 11
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 0.2%
in the last three months.
* Wall Street's median 12-month price target for Globus
Medical
Inc is $65, above its last closing price of $56.48.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.57 0.56 0.59 Beat 5.3
Sep. 30 2022 0.52 0.52 0.50 Missed -3.9
Jun. 30 2022 0.54 0.53 0.56 Beat 4.9
Mar. 31 2022 0.47 0.47 0.42 Missed -10.2
Dec. 0.47 0.47 0.49 Beat 3.7
31 2021
Sep. 30 2021 0.45 0.45 0.50 Beat 10.7
Jun. 30 2021 0.44 0.44 0.56 Beat 26
Mar. 31 2021 0.36 0.37 0.49 Beat 33.5
This summary was machine generated May 3 at 02:09 GMT. All
figures in US dollars unless otherwise stated